# Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

> **NCT01289353** · PHASE1,PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 92 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Carboplatin
- **RADIATION:** 3D-RT or IMRT

## Key facts

- **NCT ID:** NCT01289353
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-06
- **Primary completion:** 2019-07-08
- **Final completion:** 2019-07-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01289353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01289353, "Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01289353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*